Advanced Microsatellite Instability High Endometrial Carcinoma
Drug | Drug Name | Drug Description |
---|---|---|
DB15627 | Dostarlimab | An anti-PD-1 monoclonal antibody used in the treatment of mismatch repair deficient endometrial cancers and solid tumours with no alternative treatment options. |
DB09037 | Pembrolizumab | A PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB15627 | Dostarlimab | Programmed cell death protein 1 | target |
DB09037 | Pembrolizumab | Programmed cell death protein 1 | target |
DB09037 | Pembrolizumab | Programmed cell death 1 ligand 1 | target |
Drug | Drug Name | Phase | Status | Count |
---|